About Treatment Algorithm Insight Series
Decision Resources combines in-depth primary research with the most extensive claims-based longitudinal patient-level data from PharMetrics(R) to provide exceptional insight into physicians' prescribing trends and the factors that drive therapy product choice, from diagnosis through multiple courses of treatment, for a specific disease.
For each disease examined, Decision Resources' Treatment Algorithm
Insight Series provide the following:
-- Summary of U.S. medical practice based on interviews with leading
experts in the field.
-- Qualitative diagnosis/referral/treatment algorithm for the United
-- Drug usage by lines of therapy (1st, 2nd, 3rd line).
-- Discussion of key freeform combinations by lines of therapy.
-- Product share (class and specific compound level) within each line
of therapy (1st, 2nd, 3rd line).
-- Progression of therapy from key 1st line products.
-- Pathway to key therapies from previous therapies.
-- Qualitative analysis of two-year forecast incorporating upcoming
launches, changes in reimbursement, etc.
About Decision Resources
Decision Resources, Inc., (http://www.decisionresources.com) is a world leader in healthcare market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets.
All company, brand, or product names contained in this document may be
trademarks or registered trademarks of their respective holders.
For more information, con
|SOURCE Decision Resources|
Copyright©2008 PR Newswire.
All rights reserved